Skip to main content

Funded Grants

Filter by:
Clear Filters
Filter by:

886 results found

Regulation of endosomal membrane trafficking by C9ORF72 in ALS

Dr. Peter McPherson, professor at the Montreal Neurological Institute, McGill University will receive one year of support to work on the connection between the most prominent known cause of ALS, a mutation in a gene called C9ORF72, and a previously unrelated critical cellular function called endosomal membrane trafficking.


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
ALS Canada - Brain Canada Discovery Grants
Province
Québec
Start Date
2016

A Novel Microfluidic Platform for Investigating Axonal Sprouting in Motor Neurons

Motor neurons are extremely complex cells. Not only do they have an intricate set of inner workings, but they have a long wire-like portion called an axon that connects the central nervous system to muscles called an axon.


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
ALS Canada - Brain Canada Discovery Grants
Province
Alberta
Start Date
2016

A Randomized Controlled Trial of Pimozide in Subjects with ALS

This project is a Phase II study involving 100 participants across 8 ALS clinics across Canada. The trial, led by the Principal Investigator of the Canadian Neuromuscular Disease Registry (CNDR) and the Chair of the Canadian ALS Research Network (CALS) will examine whether pimozide, a drug already approved by Health Canada for use in psychoses like schizophrenia and Tourette’s syndrome, might slow progression of ALS.


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
ALS Arthur J. Hudson Translational Team Grant
Province
Alberta
Start Date
2016

Novel mechanisms regulating intraneuronal Tau clearance as potential targets for Alzheimer’s disease

In Alzheimer’s disease (AD), the accumulation of toxic Tau protein in neurons leads to the formation of neurofbillary tangles, cell death, and cognitive impairments.


Grant type
Capacity building grants
Area of Research
Neurodegeneration
Competition
Alzheimer's Society Research Program (ASRP)/Brain Canada New Investigator & Career Change Grants
Province
Québec
Start Date
2016

Role of mitochondrial c-Src kinase in Alzheimer’s disease

Mitochondrial dysfunctions are observed before and during the progression of Alzheimer’s disease (AD).


Grant type
Capacity building grants
Area of Research
Neurodegeneration
Competition
Alzheimer's Society Research Program (ASRP)/Brain Canada New Investigator & Career Change Grants
Province
New Brunswick
Start Date
2016

Tracking Alzheimer’s disease progression at the earliest stages: a multimodal project

New neuroimaging techniques enable us to measure the key hallmarks of Alzheimer’s disease (AD) pathology before symptoms appear.


Grant type
Capacity building grants
Area of Research
Neurodegeneration
Competition
Alzheimer's Society Research Program (ASRP)/Brain Canada New Investigator & Career Change Grants
Province
Québec
Start Date
2016

A Patient-Derived hiPSC Neuronal Platform for Drug Discovery in Parkinson’s Disease and Amyotrophic Lateral Sclerosis

Parkinson’s Disease (PD) and Amyotrophic Lateral Sclerosis (ALS) are two of the most common and devastating neurodegenerative diseases, affecting more than 2% of the population over the age of 65.


Grant type
Platform grants
Area of Research
Neurodegeneration
Competition
CQDM - Brain Canada - Focus on Brain
Province
Québec
Start Date
2016

Preclinical development of a disease modifying small molecule therapy for Alzheimer disease

No medications exist that can stop or even slow the progression for Alzheimer Disease (AD).


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
BC Alzheimer's Research Award Program
Province
British Columbia
Start Date
2015

2015 Dr. Hubert van Tol Travel Fellowship

Dr. Lutz is currently completing his post-doctoral fellowship entitled “Epigenetic mechanisms of childhood maltreatment”, in which he investigates the strong relationship between childhood malnutrition and mental health outcomes.


Grant type
Capacity building grants
Area of Research
Mental Health
Competition
Dr. Hubert van Tol Travel Fellowship
Province
Québec
Start Date
2015

Non Invasive Identification of Aβ Plaques in Human Retina for the Diagnosis of Alzheimer’s Disease

Currently, AD diagnosis can only be confirmed post-mortem by observing two AD hallmarks in the brain, β-amyloid (Aβ) plaques and tau strands.


Grant type
Platform grants
Area of Research
Neurodegeneration
Competition
CQDM - Brain Canada - Focus on Brain
Province
Québec
Start Date
2015